Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: United Kingdom Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20064
20078
20083
20099
20103
20114
20129
20138
20146
20157
20169
20174
20184
20196
20202
20218
20228
20236
20243
202510
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Recruiting22
Active, not recruiting20
Terminated18
Unknown status9
Withdrawn1
Approved for marketing1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences11
Hoffmann-La Roche11
AbbVie9
Acerta Pharma BV7
BeOne Medicines7
Janssen Research & Development, LLC7
Loxo Oncology, Inc.6
Celgene5
Pharmacyclics LLC.4
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell136
Lymphoma, Non-Hodgkin34
Lymphoma, Follicular26
Lymphoma, Mantle-Cell24
Lymphoma, B-Cell, Marginal Zone22
Lymphoma, Large B-Cell, Diffuse21
Lymphoma17
Recurrence17
Waldenstrom Macroglobulinemia17
Leukemia15

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.